← Eichor
Study identifier: NCT06774248 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Expanding the Youth Opioid Recovery Support (YORS) Intervention for MOUD Adherence to Adolescents With OUD

Condition: Opioid Use Disorder  ·  Sponsor: Potomac Health Foundations

PhaseNA
Planned participants80
Who can joinAll sexes, 13 Years to 21 Years
Healthy volunteersNo

About this study

Despite rising rates of fatal opioid overdoses in the United States, adolescents with OUD are far less likely than adults to receive and be retained on medication for opioid use disorder (MOUD). The multicomponent Youth Opioid Recovery Support (YORS) intervention for young adults seeks to increase adherence to extended-release MOUD and reduce opioid relapse through family involvement, assertive outreach, low-barrier access to MOUD, and contingency management. By expanding investigations of the evidence based YORS intervention to adolescents, especially those on sublingual buprenorphine, this project will significantly contribute to our knowledge base of practical strategies to address the opioid crisis in youth.

This description comes directly from the study's public registry record.

Talk to the study team

Kevin Wenzel, PhD  ·  410-233-1400  ·  kwenzel@marylandtreatment.org

Marc Fishman, MD  ·  410-233-1400  ·  mfishman@marylandtreatment.org

Always discuss trial participation with your own doctor first.

Locations (1)

Maryland Treatment CentersBaltimore, Maryland, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06774248